Quintal Pharmaceuticals [top] Jun 2026

Eight years later, in 1982, Dennis Gillings formally incorporated Quintiles Transnational as a privately held company. It began as a small team of statisticians and college students, offering data-driven insights to help pharmaceutical companies navigate the complexities of drug development. The company’s early work focused on biostatistics and data management, services that were just beginning to be recognized as critical for obtaining regulatory approval for new drugs.

While not a household name like Pfizer or Novartis, has carved out a specific niche in the generic and specialty medication market. This article explores the company’s positioning, product portfolio, regulatory standing, and what healthcare professionals need to know before sourcing from them. quintal pharmaceuticals

As oncology research entered the era of precision medicine, Quintiles was at the forefront of transforming the model for testing new therapies. They developed end-to-end solutions to connect genomic testing directly with clinical trials, a crucial step for matching patients with the right biomarker-targeted therapies. This approach supported the needs of patients, physicians, and drug developers in a rapidly evolving scientific landscape. Eight years later, in 1982, Dennis Gillings formally